BUPIVACAINE HCL-BACLOFEN PF INJECTABLE 40MG-4000MCG/ML, 21 mL syringe, Rx only, Med Shop Total Ca...

FDA Drug Recall #D-0704-2021 — Class I — October 5, 2020

Recall Summary

Recall Number D-0704-2021
Classification Class I — Serious risk
Date Initiated October 5, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Med Shop Total Care Inc.
Location Longview, TX
Product Type Drugs
Quantity 21 mL

Product Description

BUPIVACAINE HCL-BACLOFEN PF INJECTABLE 40MG-4000MCG/ML, 21 mL syringe, Rx only, Med Shop Total Care 470 East Loop 281 Longview, TX 75605

Reason for Recall

Non-Sterility

Distribution Pattern

Texas and Puerto Rico

Lot / Code Information

Lot #: 09282020@94 BUD: 10/27/2020

Other Recalls from Med Shop Total Care Inc.

Recall # Classification Product Date
D-0714-2021 Class I SUFENTANIL-BUPIVACAINE-BACLOFEN PF 25MCG-12.5MG... Oct 5, 2020
D-0717-2021 Class I HYDROMORPHONE HCL-BUPIVACAINE HCL PF INJECTABLE... Oct 5, 2020
D-0715-2021 Class I MORPHINE-BUPIVACAINE-FENTANYL PF 30MG-15MG-2000... Oct 5, 2020
D-0713-2021 Class I MORPHINE-BUPIVACAINE-KETAMINE PF INJECTABLE 21 ... Oct 5, 2020
D-0705-2021 Class I BUPIVACAINE HCL-LIORESAL PF INJECTABLE 7.5MG-16... Oct 5, 2020

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.